Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan

A current view of perlecan in physiology and pathology: A mosaic of functions

(2017) Maria A. Gubbiotti et al.   MATRIX BIOLOGY

Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications

(2016) Jelena Rnjak-Kovacina et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling

(2014) Megan S. Lord et al.   MATRIX BIOLOGY

Recombinant production of proteoglycans and their bioactive domains

(2013) Megan S. Lord et al.   FEBS Journal

Sulfation of the Bikunin Chondroitin Sulfate Chain Determines Heavy Chain·Hyaluronan Complex Formation

(2013) Megan S. Lord et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1

(2013) Megan S. Lord et al.   MATRIX BIOLOGY

Mast Cells Produce Novel Shorter Forms of Perlecan That Contain Functional Endorepellin

(2012) MoonSun Jung et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the α2β1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)

(2011) Atul Goyal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents

(2011) Boyeon Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

The modulation of platelet and endothelial cell adhesion to vascular graft materials by perlecan

(2009) Megan S. Lord et al.   BIOMATERIALS

Urinary proteomic analysis of chronic allograft nephropathy

(2008) Edmond O'Riordan et al.   Proteomics Clinical Applications

Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer

(2007) Jong Wook Chang et al.   Proteomics Clinical Applications